A major challenge for people who have a form of diabetes is the need to regulate the glucose levels in their body. Normally this is where the body’s insulin-producing cells would respond to glucose ...

*A gene therapy that may eliminate, or significantly reduce, the need for daily insulin injections is preparing to enter ...

The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers ...

A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...

Please provide your email address to receive an email when new articles are posted on . A group of experts updated the FITTER insulin injection recommendations for the first time since 2016. The ...

For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug before it could work—forcing millions of patients to rely on daily injections.

March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control ...

The primary factor behind diabetes is that your body may not make enough insulin (type 1 diabetes) or it fails to respond to the insulin your pancreas releases, which is known as insulin resistance ...

If youre on insulin to treat type 1 or type 2 diabetes, its critical to know exactly how to use it. Insulin can be a very dangerous drug if used improperly, says Stanley Mathew, MD, an endocrinologist ...

Insulin is a fragile molecule that doesn’t survive the journey through the stomach to the intestines, where it can be absorbed into the bloodstream. Encapsulating it in different materials can help, ...

Data were obtained through an Internet survey of U.S. adults self-identified as taking insulin to treat type 1 or type 2 diabetes; the survey was conducted 13 June to 7 July 2008 by Harris Interactive ...

Keeping track of insulin dosage and figuring out the right injection angle can be a challenge for people living with diabetes. A new company called nGageIT Digital, has just finished validation trials ...